Abstract:FOXN1 performs a pivotal role in the development of thymic epithelium. Homozygous FOXN1 deficiency results in T-B+NK+ SCID while FOXN1 haploinsufficiency is associated with T cell lymphopenia and nail dystrophy. We report two patients with variants of uncertain significance (VUS) in FOXN1 who presented with lymphopenia detected on newborn screening. Patient A is a 17-month-old female born to non-consanguineous parents who presented with lowT-cell receptor excision circles (TRECs). At 2 weeks old, her lymphocyte subset panel revealed low T cells, but normal B and NK cells (Table 1). Follow up at 3 months revealed uptrending T cells and significantly decreased B cells. She had no concerning clinical features or infections at that time. By 6 months, her T cells were again downtrending, but her B cells had normalized. She required antibiotics for acute otitis media, which quickly resolved. At 15 months, T cell lymphopenia persisted (Figure 2). Her infection history was reassuring, developmental milestones met and physical exam notable only for spooned nails. Patient B is a 4-month-old female also born to non-consanguineous parents presenting with low TRECs. Initial workup at 5 days revealed T cell lymphopenia, but normal B and NK cells (Table 1). At 2 months, CD4 lymphopenia persisted though CD8T cells normalized (Figure 2). She had a self-limiting upper respiratory infection, but otherwise unremarkable infection history. Development and physical exam were normal. A targeted 429-gene panel for inborn errors of immunity revealed heterozygous FOXN1 VUSs in both Patient A (c.890T > G, p.Ile297Ser) and Patient B (c.890T > C, p.Ile297Thr). Patient A's variant was not present in population databases. Patient B's variant has been observed (gnomAD frequency of 0.007%) but not present in population databases for the patient's ethnicities. Surprisingly, both are located at the same position within the Forkhead domain (Figure 1). Algorithms to predict the effect of missense changes on FOXN1 protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all predicted these variants as likely to be disruptive. Further understanding of the phenotypes associated with heterozygous FOXN1 variants of uncertain significance is crucial to guiding diagnostics, treatment, and prognosis. Table 1 Lymphocyte panel results at original presentation (Patient A: 2 weeks old, Patient B: 5 days old). Reference ranges obtained from J Allergy Clin Immunol, Volume 112, Number 5, pp 973–980, November 2003 Variant CD4+ CD45RA+ (Naïve CD4+ T Cells, cells/μL) CD4+ CD45RO+ (Memory CD4+ T cells, cells/μL) CD8+ T Cells (cells/μL) CD19+ B Cells (cells/μL) CD16+ CD56+ (NK Cells, cells/μL) Patient A c.890T>G (p.Ile297Ser) 633 100 518 423 700 Patient B c.890T>C (p.Ile297Thr) 569 126 122 610 311 Ref range (0–3 months) 1200–3700 60–900 560–1700 300–2000 170–1700 Figure 1 FOXN1 domains with locations of variants found in Patient A and B. Numbers above domains indicate amino acid number in the FOXN1 protein chain. Abbreviations: FKD, Forkhead domain; TA, transactivation domain. Figure 2: (abstract: 168) CD4+ and CD8+ trends.

Utilization of next-generation sequencing to define the role of heterozygous FOXN1 variants in immunodeficiency

Novel heterozygous FOXN1 mutation identified during newborn screening for severe combined immunodeficiency is associated with improving immune parameters

Targeted Sequencing Identifies A Novel Sh2d1a Pathogenic Variant In A Chinese Family: Carrier Screening And Prenatal Genetic Testing

Abnormal Newborn Screening for Severe Combined Immunodeficiency due to CD4 T cell lymphopenia associated with Heterozygous FOXN1 Variants in the Forkhead Domain

FOXN1 Gene Considerations in Severe Combined Immunodeficiency Treatment in Children

Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations

Characterization of Human FOXN1 Mutations Uncovers both Loss- and Gain-of-Function Outcomes

Defining the impact of FOXN1 variants with functional assays and reaggregate thymus organ cultures reveals those with loss- and gain- of function and dominant negative consequences

Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies

High-Frequency Exon Deletion Of Dna Cross-Link Repair 1c Accounting For Severe Combined Immunodeficiency May Be Missed By Whole-Exome Sequencing

Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

A novel pathogenic mutation on Interleukin-7 receptor leading to severe combined immunodeficiency identified with newborn screening and whole exome sequencing

Pathogenic Missense Mutation Pattern of Forkhead Box Genes in Neurodevelopmental Disorders

A Novel Case of IFNAR1 Deficiency Identified a Common Canonical Splice Site Variant in DOCK8 in Western Polynesia: The Importance of Validating Variants of Unknown Significance in Under-Represented Ancestries

A Copernican Revolution of Multigenic Analysis: A Retrospective Study on Clinical Exome Sequencing in Unclear Genetic Disorders

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair

NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome

Clinical exome sequencing data from patients with inborn errors of immunity: cohort level meta-analysis and the benefit of systematic reanalysis

Children with Critical Illness Carry Risk Variants Despite Non-Diagnostic Whole Exome Sequencing

Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis